SAN DIEGO — Patients with Philadelphia chromosome-negative accelerated- or blast-phase myeloproliferative neoplasms who received allogeneic hematopoietic stem cells had a longer median OS than those ...
—These investigators took a long look at prognosis and survival in patients with CML-BP in the context of TKI treatment. Patients with chronic myeloid leukemia in the blast phase (CML-BP) pose a ...
Unlike other types of cancer, doctors use phases rather than stages to describe the progression of chronic myeloid leukemia (CML). The phases of CML include the chronic phase, accelerated phase, and ...
Intensive chemotherapy provided the longest overall and progression-free survival, especially in blast phase MPN patients. Venclexta-based treatments did not significantly improve progression-free ...
At the recent American Society of Hematology annual meeting, researchers presented real-world outcomes for patients with blast-phase chronic myeloid leukemia (CML) using data from a multi-institution ...
Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma The defining molecular abnormality that drives leukemogenesis in CML is ...
Chronic myeloid leukemia (CML) is a blood and bone marrow cancer. It results in the production of too many immature blood cells, called myeloblasts. Doctors can classify CML into 3 phases using lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results